Bringing Your Prescriptions to Residential Treatment: Medication Reconciliation, Controlled Medications, and What to Tell Admissions

, ,
Mental Health Treatment | Bodhi Addiction & Wellness

Most people calling about residential treatment ask about insurance, length of stay and what to pack. Far fewer ask the question that most often causes a problem on admission day: what happens to the medications I already take? Blood pressure pills, an antidepressant, an inhaler, a stimulant for ADHD, a sleep aid, a benzodiazepine prescribed years ago. Every one of them has to be accounted for before the first night, and the process that does it has a name: medication reconciliation.

This guide explains how that process works in a residential setting, why controlled prescriptions are handled differently, and exactly what to have ready before you call admissions.

What Medication Reconciliation Means in Residential Treatment

Medication reconciliation in residential addiction treatment is the process of comparing every medication a person reports taking, including prescriptions, over-the-counter products and supplements, against pharmacy records and prescriber information, so the medical team can decide on the first day which medications continue unchanged, which are adjusted, which are tapered under supervision, and which are paused. It is completed at intake and repeated at discharge, and it depends heavily on how complete and accurate the list the person brings with them is.

In practice, the medical team is answering four questions for each item: Is it actually prescribed to this person? Is it being taken as prescribed? Does it interact with withdrawal management or with medications for addiction treatment? And is stopping it suddenly safe?

Why Controlled Prescriptions Get a Closer Look

Most routine medications, such as those for blood pressure, thyroid, diabetes or asthma, simply continue. The closer review is reserved for medications that can cause dependence or that change how withdrawal behaves.

Benzodiazepines: stopping them abruptly after regular use can cause seizures, so any change must be a supervised taper, never a sudden stop.

Opioid pain medications: combined with benzodiazepines or alcohol they raise the risk of dangerously slowed breathing, which affects how both are managed.

Stimulants prescribed for ADHD: the team weighs the documented diagnosis against current substance use before deciding whether to continue, adjust or pause.

Sleep medications and sedating supplements: these can stack with withdrawal medications and with each other, so the full list matters, including products bought without a prescription.

The U.S. Food and Drug Administration (FDA) has addressed the risks of benzodiazepine and opioid prescriptions directly. In August 2016 it required boxed warnings, its most prominent safety label, on opioid and benzodiazepine products about the dangers of using them together. In September 2020 it required the boxed warning on all benzodiazepines to be updated to describe the risks of misuse, addiction, physical dependence and withdrawal reactions. Those two dated label changes are a large part of why residential addiction treatment programs handle these prescriptions with extra care rather than continuing them automatically. The National Institute on Drug Abuse (NIDA) also publishes plain-language information on prescription medication misuse that families may find useful.

A Safety Point That Overrides Everything Else

If you or your loved one drinks heavily every day, or takes a benzodiazepine daily, do not stop on your own in the days before admission to “get a head start.” Withdrawal from alcohol and from benzodiazepines can cause seizures and, in severe cases, can be life-threatening. Medical supervision is required. The safest plan is usually to continue as you are, report your use honestly, and let the medical team manage the transition. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) describes alcohol withdrawal as a condition that can require medical treatment, and the American Society of Addiction Medicine (ASAM) publishes clinical guidelines for managing it.

If you are unsure whether it is safe to wait until admission, call us at (877) 328-1968 and ask to speak with someone about it before you change anything.

What We See Go Wrong on Admission Day

From years of admissions work in Northern California, the medication problems we see are rarely dramatic. They are logistical, and almost all of them are preventable:

  • Pills in a pill organizer or a plastic bag. Medications that are not in the original pharmacy-labeled container usually cannot be identified and verified, so they cannot be given until a replacement is obtained. That can mean a delay of a day or more for a medication the person depends on.
  • A list from memory. People commonly forget the inhaler, the eye drops, the once-weekly injection, or the supplement they take every night. Each omission is a gap in the medical picture.
  • Prescriptions from several prescribers. When a primary care doctor, a psychiatrist and a pain specialist each prescribe something, no single office has the whole list. The treatment team may be the first to see it all together.
  • Underreporting use. Saying “two drinks a night” when it is closer to a bottle, or “as prescribed” when it is twice the dose, does not change what the body will do in withdrawal. It only means the plan is built on the wrong numbers.

None of these reflect badly on the person. They are what happens when someone is preparing for treatment under stress. They are also easy to fix in advance.

What to Do Before You Call Admissions

Here is a short checklist you can complete today, before the admissions call or before admission day:

  1. Gather every bottle. Put every prescription, over-the-counter medication and supplement you have taken in the last 30 days on one table, in its original labeled container.
  2. Write one list. For each item, write the name, the dose, how often you actually take it, the prescriber, and the pharmacy. “Actually” matters more than “supposed to.”
  3. Call your pharmacy. Ask for a printed medication history. Most pharmacies can provide one, and it often catches items people forget.
  4. Flag the controlled ones. Circle anything that is a benzodiazepine, an opioid, a stimulant or a sleep medication, and note how long you have taken it.
  5. Ask these three questions on the admissions call: “Which of my medications will continue on day one?” “If a medication needs to be tapered, who sets the schedule?” “If something I take is not continued, will my prescriber be told?”

Bring the list, the bottles and the pharmacy printout on admission day. Admissions can tell you about any program-specific rules, such as how medications are stored and dispensed. You can start that conversation at (877) 328-1968.

What Happens After Intake

Once the medical team has the list, decisions are typically made in the first hours or day. Continued medications are usually stored and dispensed by staff rather than kept by the person. Medications that are tapered follow a written schedule. If a medication for addiction treatment, such as buprenorphine or naltrexone, is part of the plan, it is checked against everything else on the list first.

Reconciliation happens again at discharge. That second pass is just as important: the person should leave with a single, current list, a clear note on anything that was changed and why, and confirmation that the outpatient prescriber has been informed. If you are planning the step after residential care, our pages on partial hospitalization and outpatient treatment explain how care typically continues. You can also read about our approach to residential treatment.

For Families Helping With Preparation

Families often end up doing the practical work: collecting bottles from the bathroom cabinet, calling the pharmacy, finding the psychiatrist’s phone number. That help is valuable. It works best when the person entering treatment is part of it, because only they know what they actually take and how often. If your loved one is reluctant to share details with you, encourage them to share them directly with admissions instead. The goal is an accurate list, not who compiles it.

For confidential, free help finding treatment and support at any hour, the SAMHSA National Helpline is available 24 hours a day, 365 days a year, at 1-800-662-4357. If you or someone you love is in crisis or thinking about suicide, call or text 988. In an emergency, call 911.

Talk to Bodhi Before You Change Anything

If you are preparing for residential treatment and are unsure what to do with a current prescription, the most useful step is a conversation before admission, not on the day. Call Bodhi Addiction Treatment at (877) 328-1968 to talk through your medications, your use and what to bring.

This article is for educational purposes only and is not medical advice. Do not start, stop or change any medication without guidance from a qualified healthcare provider. Withdrawal from alcohol or benzodiazepines can be dangerous and requires medical supervision.

/by

Leaving Residential Treatment Against Medical Advice: What Happens, the First 24 Hours, and What to Ask For Before You Go

, ,
Capitola Beach — Bodhi Addiction Treatment & Wellness

Most people who think about leaving residential treatment early do it in the first week, often between day three and day seven. Withdrawal is easing, sleep is still broken, the novelty has worn off, and a voice says, “I’m fine now. I can do the rest at home.” Families get the phone call that starts with “Come pick me up.”

This guide explains what actually happens when someone leaves residential treatment against medical advice (AMA), why the first 24 hours afterward carry real medical risk, and the specific things to ask for before walking out the door. It is written from the admissions and clinical side of residential care in Northern California, where these conversations happen every week.

What “Against Medical Advice” Means in Residential Treatment

Leaving against medical advice means a person ends their stay before the treatment team recommends discharge. For an adult who admitted voluntarily, residential treatment is not a locked setting, and the program generally cannot hold someone who chooses to leave. What staff can do is slow the moment down, make sure the person is medically safe to go, and send them out with a plan instead of nothing.

In practice, an AMA discharge usually involves a conversation with a counselor or clinical lead, a check with medical staff about current withdrawal status and medications, and a form acknowledging that discharge is against the team’s recommendation. Signing that form does not erase the person’s record or bar them from coming back. It documents that the risks were explained.

Why People Leave Early: The Common Triggers

The reasons people give for leaving are usually not the real reasons. In residential work, the same handful of pressures show up again and again:

  • Post-acute withdrawal discomfort: Poor sleep, irritability, and low mood can linger for days or weeks after acute withdrawal ends, and they feel like proof that treatment “isn’t working.”
  • Cravings that peak without warning: A craving can arrive as a sudden, urgent certainty that leaving is the only reasonable choice, then fade within hours if the person stays put.
  • Outside pressure: A partner, employer, landlord, or court date creates a deadline that feels more pressing than the remaining days of care.
  • Conflict on the unit: A disagreement with a peer or staff member turns into “this place isn’t right for me.”
  • Feeling better too fast: Once the fog lifts, it is easy to mistake physical stabilization for recovery and conclude the job is done.

Naming the trigger matters, because most of them have a fix that does not require leaving: a medication adjustment, a room change, a call with the employer, a family session.

The Medical Risks in the First 24 Hours After Leaving

Leaving early is not only a setback in progress. Depending on the substance, it can be physically dangerous.

Alcohol and benzodiazepines: If someone leaves while still in withdrawal from alcohol or partway through a benzodiazepine taper, they can develop seizures and other serious complications. Withdrawal from either should only happen under medical supervision. Stopping a taper abruptly, or drinking to “take the edge off” after leaving, can make things worse. If a person who has left shows confusion, shaking, hallucinations, or a seizure, call 911.

Opioids and lost tolerance: After even a short period without opioids, tolerance drops. Returning to a previous amount, especially in a drug supply that may contain fentanyl, can cause an overdose. According to the National Institute on Drug Abuse (NIDA), naloxone can rapidly reverse an opioid overdose and quickly restore normal breathing, and it is available as a prepackaged nasal spray that requires no assembly.

Interrupted medications: People leaving mid-stay may be partway through starting buprenorphine, a psychiatric medication, or a medication for alcohol use disorder. Leaving without a prescription or a follow-up appointment can create a gap at the worst possible time.

Before You Walk Out: Five Things to Ask For Today

If you or someone you love has decided to leave residential treatment early, these five requests take less than an hour and can be the difference between a rough week and an emergency. Ask the staff, in this order:

  1. A medical check before you go. Ask the nurse or medical provider, “Am I medically safe to leave today, and what symptoms should send me to the ER?” Write the answer down.
  2. Your current medication list and prescriptions. Ask for printed copies of every medication, dose, and the next scheduled dose, plus prescriptions or a bridge supply where appropriate.
  3. Naloxone, if opioids are part of the history. Ask for a naloxone kit to take home, and make sure someone in the household knows where it is kept.
  4. A next appointment, not a phone number. Ask staff to book a specific date and time with an outpatient provider, a partial hospitalization program, or an outpatient program before you leave the building.
  5. The readmission question. Ask directly, “If I change my mind in a day or a week, what is the process to come back?” Knowing the door is open makes it easier to walk back through it.

A practical step for families: if your loved one calls asking to be picked up, ask them to wait 30 minutes and talk to their counselor first, then call the program yourself. Many urges to leave pass in that window.

What Families Can Do When the “Come Get Me” Call Comes

That phone call is hard. You want your loved one to be comfortable, and you also know what happened the last time they came home early. A few things help:

  • Stay calm and ask what happened today, rather than arguing about leaving.
  • Tell them you love them and that you support them finishing treatment.
  • Ask whether they have talked with their counselor or the medical team yet.
  • If they leave anyway, focus on safety: naloxone in the house, a follow-up appointment on the calendar, and a clear plan for what you will do if symptoms of withdrawal or overdose appear.

Families can also call our admissions team for guidance on how to handle the conversation, even if the person is in treatment somewhere else. Reach us at (877) 328-1968.

Free Help Is Available at Any Hour

Leaving residential treatment early does not end the option of getting help. SAMHSA’s National Helpline, 1-800-662-HELP (4357), is a free, confidential treatment referral and information service that operates 24 hours a day, 365 days a year, in English and Spanish, for individuals and families facing mental health or substance use disorders, according to the Substance Abuse and Mental Health Services Administration (SAMHSA). If someone has left treatment and is struggling at 2 a.m., that line is answered.

If someone is in immediate danger or is having thoughts of suicide, call or text 988 or call 911.

Leaving Is Not the End of the Story

An AMA discharge is common, and it is not a moral failure. Many people who leave early come back, sometimes within days, and do well the second time because they understand what they are walking into. What matters most is that the person leaves with a medical check, their medications, naloxone where relevant, and a real appointment, and that everyone knows how to come back.

If you are weighing whether to leave treatment, or trying to help someone who already has, talk to us first. Call (877) 328-1968 to speak with our admissions team about next steps, readmission, or a lower level of care that fits where you are now.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Withdrawal from alcohol or benzodiazepines can cause seizures and requires medical supervision. Always talk with a qualified healthcare provider about your specific situation. If you are experiencing a medical emergency, call 911.

/by

Nicotine in Residential Treatment: Smoking Policies, the Seven FDA-Approved Quit Medications, and What to Ask Admissions

, ,
Peaceful natural setting representing mindfulness practice in addiction recovery

Almost every admissions call eventually gets to the same question, usually asked a little sheepishly: “Can I smoke there?” or “Can I bring my vape?” It sounds like a small logistics detail next to detox and insurance. In practice, nicotine shapes the first week of residential treatment more than most people expect, and a plan for it, made before admission day, removes one of the most common reasons people feel like leaving early.

This guide covers how nicotine is usually handled in residential drug and alcohol treatment, which medications exist, how nicotine withdrawal overlaps with other withdrawal, and the specific questions to ask admissions before you arrive.

Why Nicotine Belongs in the Treatment Plan

Tobacco and nicotine use are far more common among people with substance use disorders than in the general population, a pattern documented by the National Institute on Drug Abuse (NIDA). For a long time, many programs treated cigarettes as the one habit to leave alone during recovery, on the theory that quitting everything at once was too much. That view has shifted. Federal guidance from SAMHSA encourages behavioral health programs to address tobacco as part of care rather than set it aside, and research summarized by NIDA generally suggests that working on nicotine during addiction treatment does not undermine recovery from other substances and may support it.

That does not mean anyone is required to quit nicotine the day they walk in. It means nicotine is a clinical question that deserves an answer in the admission plan, the same way sleep, medications, and withdrawal do.

The Seven FDA-Approved Quit Medications

The U.S. Food and Drug Administration has approved seven medications to help people quit smoking, according to the Centers for Disease Control and Prevention (CDC): five forms of nicotine replacement (the patch, gum, lozenge, inhaler, and nasal spray) and two non-nicotine prescription pills, varenicline and bupropion. A person entering residential treatment in California can ask admissions which of these seven the program can continue, order, or start on site, and whether a combination such as a patch plus gum or lozenges is used, since pairing a long-acting and a short-acting form is a common clinical approach.

A few practical points about these medications in a residential setting:

  • Nicotine replacement can start on day one. Patches and gum do not require a quit date to be set in advance, which makes them the most common option during the first days of a stay.
  • Varenicline and bupropion take time to build. Both are typically started before a planned quit date rather than on it. The prescribing clinician sets the schedule, so this is worth raising early in a stay rather than the week before discharge.
  • Bupropion needs a medical review. It is not appropriate for everyone, including people with a seizure history or those currently withdrawing from alcohol or sedatives. That decision belongs to the medical team.
  • Insurance and cost vary. Coverage for quit medications differs by plan. When you verify your insurance, it is reasonable to ask whether tobacco cessation medications are covered.

Why Nicotine Withdrawal Gets Confused With Everything Else

One of the most useful things we see in the first week is simply naming what is nicotine. People arrive already dealing with withdrawal from alcohol, opioids, stimulants, or sedatives. If their nicotine intake also drops sharply because smoking is limited to set times and places, a second withdrawal stacks on top of the first, and the two are hard to tell apart from the inside.

The overlap is real. Nicotine withdrawal commonly brings these, often within the first few days of cutting down:

  • Irritability: a short fuse that often gets read as “treatment isn’t working” or “I don’t belong here.”
  • Restlessness and poor concentration: the same complaints people have during early alcohol or stimulant withdrawal, which makes groups feel unbearable.
  • Sleep disruption: already common in early recovery, and nicotine changes can make it worse.
  • Cravings that blur together: an urge for a cigarette and an urge for the primary substance can feel like one undifferentiated “I need something.”

The practical consequence is that someone can decide to leave treatment over discomfort that a nicotine patch would have eased. In our experience, asking “When did you last have nicotine, and how much do you usually use in a day?” is one of the most clarifying questions on intake, and it often changes the plan for the first 72 hours.

An important safety note: nicotine withdrawal is uncomfortable but not medically dangerous. Withdrawal from alcohol or benzodiazepines is different and can cause seizures. If you are stopping alcohol or a benzodiazepine, medical supervision is required. Do not reduce or stop those substances on your own before admission without speaking to a medical provider. Our residential treatment program coordinates withdrawal management with medical staff for exactly this reason.

Smoking, Vaping, and House Rules

Policies differ widely between residential programs in California. Some allow smoking in a designated outdoor area at set times. Some are entirely tobacco-free on the property. Many restrict vapes specifically, because cartridges are easy to refill with substances other than nicotine and are hard for staff to check. None of these policies is wrong, but finding out about them on admission day, without a replacement plan, is how people end up miserable in week one.

Families also notice something worth knowing: smoke breaks become social. In programs that allow them, the smoking area is often where people talk most openly. That is not a reason to keep smoking, but it explains why people resist giving it up in the middle of treatment, and why a plan that respects that reality tends to work better than an ultimatum.

What to Do Before Admission Day

Here is a short check you can run this week if you or a family member is preparing for residential treatment.

  1. Write down your actual daily nicotine use. Cigarettes per day, vape pods per day, or pouches per day, plus how soon after waking you use. These numbers are what the medical team uses to choose a replacement dose.
  2. Ask admissions three specific questions: Is the property tobacco-free, or is smoking allowed in a designated area? Are vapes permitted, and if not, what happens to one I bring? Which nicotine replacement products or quit medications can you provide on day one?
  3. Ask whether nicotine is addressed in the treatment plan. You are not committing to quit by asking. You are making sure someone has thought about it.
  4. Do not stockpile. Bringing cartons or extra vapes usually results in them being held at intake. Bring the information instead.

If you want help working through these questions, call our admissions team at (877) 328-1968. We can tell you how nicotine is handled on site and what medication options are available before you commit to a date.

After Discharge: Keeping Nicotine in the Plan

Whatever someone decides about nicotine during a residential stay, the decision should carry into the discharge plan. If a person started nicotine replacement or a prescription quit medication in treatment, the discharge paperwork should say which product, what dose, and who will continue prescribing it. Gaps in that handoff are common, and a person who runs out of patches in the second week home is facing nicotine withdrawal at the same moment they are adjusting to life outside a structured setting.

Free telephone coaching is available nationally through 1-800-QUIT-NOW, which connects callers to their state quitline, as described by the CDC. Adding that number to the discharge plan costs nothing and gives the person a resource that is available beyond office hours.

A Note From Clinical Practice

As a counselor and interventionist, I have watched nicotine decide more admissions than most people would believe. The person who is ready to stop drinking but cannot picture three weeks without a cigarette will sometimes delay treatment over that one fear. A clear, honest answer about nicotine policy and replacement options, given on the first phone call, removes the fear and keeps the focus where it belongs.

If you are weighing residential treatment for yourself or someone you love, reach out at (877) 328-1968. We will walk you through admissions, insurance, and what the first week will look like, including the nicotine question.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Medication decisions, including nicotine replacement and prescription quit medications, should be made with a qualified medical provider. Withdrawal from alcohol or benzodiazepines can be life-threatening and requires medical supervision. If you are in crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline, or call 911 in an emergency.

/by

Starting Buprenorphine in Residential Treatment: The COWS Score, Fentanyl, and What to Ask Admissions

, ,
Nurse reviewing medical records at a computer during an overnight shift in a residential detox unit

Families calling about residential treatment for opioid use often ask one question first: “Will they keep him on his medication?” The second question, usually asked later and with more worry, is “If she isn’t on anything yet, can they start it there?” Those are two different admissions questions, and programs answer them differently. This guide explains how buprenorphine is started in a residential setting, what the COWS score measures, and exactly what to confirm with admissions before the intake date.

Starting Buprenorphine Is a Timed Medical Step, Not a Prescription Handed Over

Buprenorphine is one of the medications for opioid use disorder recognized by the National Institute on Drug Abuse (NIDA) and addressed in the American Society of Addiction Medicine (ASAM) National Practice Guideline. Starting it, a process clinicians call induction or initiation, is timed. Because buprenorphine binds tightly to opioid receptors but activates them only partially, taking the first dose while full-agonist opioids such as fentanyl, heroin or oxycodone are still occupying those receptors can push a person abruptly into withdrawal. That is called precipitated withdrawal, and avoiding it is the main reason the first dose is scheduled around a measured withdrawal score rather than a clock.

In practice, the first day in a residential program that starts buprenorphine on-site looks like this: the person arrives, completes the medical intake, and is then observed. Nursing staff reassess withdrawal on a schedule. When the score shows enough withdrawal, the prescriber approves a first dose, and the person is reassessed again afterward. Many people describe that first wait as the hardest part of week one: restless legs, yawning, gooseflesh, a running nose and the feeling that time has stopped. Knowing in advance that the wait is deliberate makes it easier to get through.

What the COWS Score Measures

The Clinical Opiate Withdrawal Scale (COWS) is an 11-item clinician-rated checklist scored from 0 to 48, used to measure opioid withdrawal before and after a buprenorphine dose. A nurse rates observable signs including resting pulse, sweating, restlessness, pupil size, bone or joint aches, runny nose or tearing, gastrointestinal upset, tremor, yawning, anxiety or irritability, and gooseflesh. The commonly used bands are 5 to 12 for mild withdrawal, 13 to 24 for moderate, 25 to 36 for moderately severe, and above 36 for severe. Each program’s prescriber sets the score at which a first dose is given, so families should ask for that program’s threshold rather than assume one.

The score matters because it turns “I feel terrible” into something a prescriber can act on safely. It also gives the person in treatment something concrete: a number that is moving, which tells them the plan is working.

Why Fentanyl Changed the First Few Days

Clinicians across the field have adjusted induction practices as fentanyl has replaced heroin and pills in much of the street supply. The reasons are worth understanding before admission:

  • Fat-tissue storage: Fentanyl is highly fat-soluble and can be released from body tissue for longer than its short half-life suggests, so withdrawal may build more slowly and unevenly.
  • Unknown supply: Street pills sold as oxycodone or other opioids often contain fentanyl, so the last-use history a person gives may not reflect what they actually took.
  • Precipitated withdrawal risk: Dosing too early is more likely when fentanyl is still active, which is why some prescribers wait for a higher score or use alternative starting approaches.
  • Mixed substances: Fentanyl in the supply is frequently combined with other sedatives, which changes how a medical team monitors the first 24 to 72 hours.

Some prescribers now use lower-dose or “micro-induction” starts for selected patients, where small buprenorphine doses overlap with the existing opioid for several days. Whether a program offers that option, and for whom, is a clinical decision made by its prescriber. It is a fair question to ask.

Safety: Alcohol and Benzodiazepines Change the Plan

Opioid withdrawal is extremely uncomfortable but is rarely life-threatening on its own in otherwise healthy adults. Alcohol and benzodiazepine withdrawal are different: both can cause seizures and other dangerous complications, and both require medical supervision. Anyone who uses alcohol daily or takes benzodiazepines such as alprazolam, clonazepam or lorazepam, prescribed or not, should never stop abruptly, and must tell admissions about that use before the intake date. Combining opioids with alcohol or benzodiazepines also raises overdose risk. If you are worried someone has overdosed, call 911 immediately. For confidential treatment referral, the SAMHSA National Helpline is available 24 hours a day at 1-800-662-4357.

The Operational Truth: Not Every Residential Program Starts Buprenorphine On-Site

From placement work across our network, this is the gap families most often miss. Some residential programs will continue buprenorphine for someone who arrives already on a stable dose but do not start it on-site. Others start it routinely. Some accept people on methadone only if a dosing arrangement with an opioid treatment program can be made in advance, since methadone for opioid use disorder is dispensed through federally certified clinics. A program’s website rarely spells this out. The answer usually lives with the medical director, and the only reliable way to get it is to ask directly.

A related change helps. Since the Consolidated Appropriations Act of 2023 removed the federal “X-waiver” requirement, any clinician with a standard DEA registration that includes Schedule III can prescribe buprenorphine for opioid use disorder. That widened who can prescribe, but it did not make every residential program set up to manage an on-site start. Staffing, nursing coverage overnight and the program’s medical model still decide that.

Five Questions to Ask Admissions Before the Intake Date

Write these down and ask them on the next admissions call. Ask for the answers in writing if you can.

  1. Do you start buprenorphine on-site, or only continue it? If only continue, ask where the person would be inducted first and how the handoff works.
  2. Who is the prescriber, and how often are they available? Ask whether a prescriber can approve a dose overnight or on a weekend.
  3. What COWS score do you use before the first dose, and how often is it rechecked? A clear answer here is a good sign of an organized medical process.
  4. What is your plan for fentanyl exposure? Ask whether lower-dose starts are available and how precipitated withdrawal is managed if it happens.
  5. How does the prescription continue after discharge? Ask who writes the first outpatient prescription and whether a follow-up appointment is booked before the person leaves. A gap of even a few days after discharge is a known risk period.

If you have not yet confirmed coverage, run a benefits check at the same time; our insurance verification page explains what that check tells you. You can also call our team at (877) 328-1968 and we will help you put these questions to the programs you are considering.

What Families Usually Notice in the First Week

Families often expect the person they love to sound better on the first phone call. Sometimes they do. More often, the first call comes on day two or three and sounds flat or irritable, which is consistent with a body adjusting to a new medication and a structured schedule. By the end of the first week, many people report sleeping more normally and thinking less about using. That is the stabilization a residential treatment setting is designed to protect, so that therapy, family sessions and discharge planning can do their work.

Medication is not a shortcut around treatment, and it is not a substitute for one. It is one part of a plan, and it works best when the plan around it is clear before admission day.

Talk With Someone Who Knows the Programs

Bodhi Addiction Treatment & Wellness helps individuals and families in Northern California and beyond find residential programs that match their medical needs, including whether buprenorphine can be started or continued on-site. Learn more about our founder and clinical reviewer, Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i, or call (877) 328-1968 to talk through your options today.

This article is for educational purposes only and is not medical advice. Medication decisions, including whether and when to start buprenorphine, must be made by a licensed prescriber who has evaluated the individual. Do not stop alcohol, benzodiazepines or any prescribed medication without medical supervision. If you or someone you know is in immediate danger, call 911. For a mental health or substance use crisis, call or text 988.

/by

How Long Is Residential Treatment? How Length of Stay Is Set, Concurrent Review, and What to Ask Admissions

, ,
holistic rehab california

“How long will I be there?” is usually the first logistics question on an admissions call, and it is the one with the least satisfying answer. Families want a date so they can plan work leave, childcare and rent. The honest answer is that the length of a residential stay is not fixed on day one. It is set, and reset, by two processes running side by side: the clinical team’s ongoing assessment, and, for people using insurance, the insurer’s periodic reauthorization. Knowing how both work lets you plan for a range instead of being surprised by a single number.

The Short Answer: A Range, Reviewed in Steps

At Bodhi Addiction Treatment, residential programs commonly range from 30 to 90 days, and when a stay is covered by insurance, longer stays are typically reauthorized through concurrent review, often every 7 to 14 days. That means a person admitted to residential treatment in Northern California should not expect one approval for the whole stay; they should expect a series of short reviews, each one asking whether residential care is still the right level, and should plan work leave and family arrangements around the full 30-to-90-day range rather than the first approved block.

Those two figures come from our own residential treatment and insurance verification pages, as published on October 6, 2026. They describe how stays commonly run, not a guarantee for any one person.

Why Length of Stay Matters Clinically

The National Institute on Drug Abuse lists remaining in treatment for an adequate period of time as one of its principles of effective treatment, and notes that the right duration depends on the type and severity of a person’s problems and needs. Leaving early is one of the more common points where recovery plans come apart, which is why the first one to two weeks of a stay get so much attention from staff.

That does not mean longer is always better or that every person needs the maximum. It means the decision to step down should be made on clinical grounds, with a plan in place, rather than on a date picked before anyone knew how the first week would go.

What Actually Decides How Long a Stay Lasts

In practice, length of stay is the product of several factors working together:

  • Withdrawal and medical stability: A stay cannot meaningfully begin its therapy phase until withdrawal is managed, and alcohol or benzodiazepine withdrawal carries seizure risk that requires medical supervision.
  • Dimension-by-dimension assessment: Clinicians reassess the six dimensions in the ASAM Criteria, including relapse risk and the recovery environment, and the level of care follows those ratings.
  • Co-occurring mental health conditions: Depression, anxiety, PTSD or bipolar disorder that surface once substances clear often need time to stabilize before discharge is safe.
  • The home environment: A person returning to a household where others are actively using usually needs a stronger step-down plan, and sometimes more time, than someone returning to a stable, substance-free home.
  • Insurance authorization: The payer approves days in blocks, and each block depends on documentation showing residential care is still medically necessary.

How Concurrent Review Works, Step by Step

Concurrent review is the insurer’s process for approving a stay while it is happening. From the family’s side, it rarely looks like anything, because the conversations happen between the treatment center’s utilization review staff and the insurer’s care manager. Here is the usual sequence:

  1. Initial authorization at admission. The insurer approves an opening block of days based on the intake assessment.
  2. Clinical updates before the block ends. The treatment team sends progress notes, risk ratings and the current treatment plan.
  3. A decision on the next block. The insurer approves more days, approves fewer than requested, or determines that a lower level of care, such as a partial hospitalization program, is now appropriate.
  4. Repeat. This continues, often every 7 to 14 days, until discharge or step-down.

If an insurer stops authorizing residential days before the clinical team believes the person is ready, the center can request a peer-to-peer review between physicians, and the person has appeal rights. A step-down decision from an insurer is not the same as being told treatment is over; it often means the next phase is outpatient-based.

What We See From the Admissions Side

Jonathan Beazley has spent years on admissions and placement calls, and one pattern repeats: families plan around the number they heard first. If someone mentioned “30 days,” the employer gets told 30 days, the leave paperwork says 30 days, and a relative books a flight home for day 31. Then the first concurrent review approves a shorter block than expected, or the clinical team recommends more time, and the plans built around that single number fall over during the most fragile part of the stay.

The less convenient truth is that day 30 is not a clinical milestone. It is a convenient round number. Discharge timing that works tends to come from a written step-down plan, not a calendar.

Three Things to Do Before Admission Day

You can do each of these today, on the phone, before a bed date is set:

  1. Ask admissions this exact question: “How many days does my plan usually approve at admission for residential care, and how often does your team submit concurrent review?” Write down the answer and the name of the person who gave it.
  2. Request leave for the range, not the minimum. If you are using FMLA or California’s CFRA, ask your provider to certify an estimated duration that covers the realistic range. Extending leave mid-stay is possible but adds paperwork at a hard moment.
  3. Ask what the step-down looks like. Ask, “If insurance moves me to a lower level of care, where does that happen and does my therapist stay the same?” Continuity of the clinical relationship often matters more than the exact number of residential days.

If you would like help working through these questions, our admissions team can walk through your specific coverage at (877) 328-1968.

Questions Families Ask About Length of Stay

Can a person leave before the planned discharge? Voluntary residential treatment is voluntary, so yes. Leaving against clinical advice can carry real risk, especially for anyone who used opioids, because tolerance drops during treatment. Anyone leaving early should be offered naloxone and a follow-up appointment.

Does self-pay change the length? Without insurance there is no concurrent review, so length is set by the clinical team and by cost. Ask for the daily rate and a written estimate for the full range before admission.

What if the clinical team wants more time but insurance says no? Ask the center to request a peer-to-peer review, and ask what options exist to continue at the same level while an appeal is pending.

Getting Help

If you are trying to plan around an admission and need a straight answer on timelines and coverage, call (877) 328-1968. For free, confidential treatment referral information at any hour, the SAMHSA National Helpline is available 24 hours a day, 365 days a year. If you or someone you love is in immediate danger, call 911. For a mental health crisis, call or text 988.

This article is for educational purposes only and does not replace individualized medical advice, diagnosis or treatment. Length of stay, insurance authorization and level-of-care decisions vary by person, plan and program. Alcohol and benzodiazepine withdrawal can cause seizures and should never be attempted without medical supervision. Talk with a qualified healthcare provider about your situation.

/by

No Medication for Stimulant Use Disorder: How Residential Treatment Is Planned for Meth and Cocaine, and What to Ask Admissions

, , ,
Clinical setting where sleep after quitting meth is monitored during residential recovery

When a family calls about methamphetamine or cocaine, one of the first questions is usually some version of “What medication will they put him on?” For opioids or alcohol, there is a real answer. For stimulants, there is not, and that single fact changes how a residential stay should be planned, how long it should run, and what has to be in place on discharge day. This post walks through those planning decisions in the order admissions actually works through them.

The Short Answer: No Medication Exists Yet

According to the National Institute on Drug Abuse (NIDA), there is no FDA-approved medication for methamphetamine use disorder or for any other stimulant use disorder, including cocaine. NIDA reports that stimulant withdrawal symptoms typically peak two to three days after last use and may last about a week, while low mood, anxiety and cravings can continue for several months. Because there is no medication to bridge that gap, residential treatment for stimulant use disorder relies on behavioral treatment, with contingency management the best-studied option, alongside cognitive behavioral therapy, group support and motivational interviewing.

That paragraph is the whole planning problem in miniature. The acute phase is short. The vulnerable phase is long. And the tool that carries people through the long phase with opioids, a daily medication, does not exist here yet.

What We See in the First Week

In our admissions work, the stimulant intake that worries families most is often the quiet one. A person who arrived agitated and talking fast is, by day two or three, sleeping most of the day, eating everything on the tray and saying very little. Families on the phone read that as either “he’s fine now” or “something is wrong.” Usually it is neither. It is the crash phase NIDA describes, and it is the point where people most often decide they no longer need to be here, because the chaos that brought them in has gone quiet.

The second pattern is the one that matters for discharge planning: in our experience, a few weeks in, after sleep and appetite settle, cravings tend to return in a different form, cued by a song, a payday, a particular freeway exit. A plan built only around the first week misses this entirely.

Why Stimulant Plans Look Different

These are the mechanisms our clinical team plans around when a stimulant is the primary substance:

  • No medication bridge: without an FDA-approved medication, nothing pharmacological holds cravings down after discharge, so the behavioral plan has to be stronger and start earlier.
  • Short acute phase, long tail: withdrawal peaks within days, but NIDA notes mood and craving symptoms can last months, which is why length of stay should not be set by how someone looks on day seven.
  • Misleading recovery of energy: once sleep normalizes, people often feel better than they have in years, and that feeling is frequently mistaken for being finished with treatment.
  • Cue-driven cravings: stimulant cravings are strongly tied to people, places and routines, so the relapse-prevention plan has to name specific cues rather than general “triggers.”
  • Hidden polysubstance use: many people who use stimulants also use alcohol, benzodiazepines or opioids to come down, and that second substance can carry the greater medical risk.

The Safety Piece Admissions Must Hear

Stimulant withdrawal itself is rarely medically dangerous in the way alcohol withdrawal is, but the substances people use alongside stimulants can be. Alcohol and benzodiazepine withdrawal carry a risk of seizures and require medical supervision. If your loved one drinks heavily or takes Xanax, Klonopin, Valium or similar medications to sleep after using, tell admissions on the first call. That information changes whether medical detox is needed before residential care.

NIDA also notes that methamphetamine, alone or combined with fentanyl, contributes to the overdose crisis. Anyone who uses stimulants from an unregulated supply should have naloxone available, and anyone returning home after reduced use faces changed tolerance.

The crash phase can bring heavy depression. If someone talks about suicide, call or text 988. If there is chest pain, a seizure, severe confusion or psychosis, call 911.

Questions to Ask on the Admissions Call

Here is something you can do today. Before you commit to any program, ask these five questions and write down the answers:

  1. “How do you treat stimulant use disorder specifically?” Listen for named approaches such as contingency management or cognitive behavioral therapy, not just “individual and group therapy.”
  2. “How is length of stay decided?” A good answer references clinical reassessment over time, not a fixed number of days that happens to match an insurance authorization.
  3. “What happens if they want to leave on day three?” Ask what staff actually do, and whether family will be contacted if the person has signed consent.
  4. “Do you screen for alcohol and benzodiazepine use at intake?” The answer should be yes, with a clear path to medical detox if needed.
  5. “What does the step-down plan look like?” Ask whether they arrange outpatient treatment or intensive outpatient care before discharge, with a first appointment date already set.

If you want to talk through these with someone before calling anywhere else, our team is available at (877) 328-1968.

How Length of Stay Gets Decided

For stimulant use disorder, length of stay in residential treatment is driven by clinical criteria, typically the ASAM dimensions, rather than by withdrawal severity, because withdrawal is usually over within the first week. What clinicians are actually watching after that is relapse risk, the home environment and whether the person can name and manage their own cues.

Insurance authorizations are often issued in short blocks and reviewed. That is normal. What families should know is that a utilization review asking “why is this person still here if withdrawal is over?” is answered with documentation about relapse risk and recovery environment, not withdrawal. If you are unsure what your plan covers, you can verify insurance benefits before admission so there are no surprises at the first review.

Contingency Management: What It Is and How to Ask

Contingency management offers small, tangible incentives, such as vouchers or gift cards, for verified progress such as negative drug tests or attendance. NIDA describes it as the best-studied behavioral treatment for methamphetamine use disorder and the one most associated with treatment success. It can feel counterintuitive to families. It works in part because stimulants hijack the brain’s reward system, and small, immediate, predictable rewards help rebuild that system around something other than the drug.

Availability varies by program and payer. Ask directly whether it is offered during residential care, after discharge, or through a referral, and who pays for the incentives.

Discharge Without a Prescription

When someone leaves residential treatment for opioid use disorder, a medication often travels with them. With stimulants, the discharge plan has to carry that weight instead. Before discharge day, confirm in writing:

  • The date and time of the first outpatient or IOP appointment
  • A named list of personal cues and the plan for each
  • Whether mental health follow-up is scheduled for mood symptoms that may persist
  • Where naloxone is kept at home
  • Who the person will call in the first 72 hours if cravings spike

SAMHSA’s National Helpline, 1-800-662-HELP (4357), is a free, confidential, 24/7, 365-day-a-year referral service in English and Spanish, and it is a useful backup number to keep on the fridge.

A Note From the Clinical Side

The families who do best with stimulant treatment are usually not the ones who found the perfect program. They are the ones who stopped measuring progress by how their loved one looked in week one and started asking what the plan was for week eight. That shift alone changes the conversation with any treatment team. Learn more about Jonathan Beazley and the clinical approach at Bodhi.

If someone you love is using methamphetamine or cocaine and you are trying to figure out next steps, call us at (877) 328-1968. We can help you sort out level of care, insurance and timing, even if Bodhi turns out not to be the right fit.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Alcohol and benzodiazepine withdrawal can cause seizures and require medical supervision. If you or someone you know is in crisis, call or text 988, or call 911 in an emergency.

/by

Sober Living After Residential Treatment in California: What Is Licensed, What Isn’t, and What to Check Before Move-In

, , , ,
Clinician reviewing the cocaine withdrawal timeline with a client in residential detox

For many people finishing residential treatment, the hardest question is not whether to keep going in recovery. It is where to sleep on the night of discharge. Going straight back to the same apartment, the same roommates, and the same routines is a real risk, and sober living is often the answer families reach for. But “sober living” covers a wide range of homes in California, from carefully run residences with house managers and written standards to a rented house with a list of rules taped to the fridge. This guide explains how sober living is regulated here, what the support levels mean, and the specific things to confirm before anyone signs a lease or pays a deposit.

What Sober Living Is, and What It Is Not

In California, a sober living home that provides no treatment services generally does not need a license from the Department of Health Care Services (DHCS), the state agency that licenses residential addiction treatment facilities. That means the protections that come with a licensed residential treatment program, such as required staffing, clinical oversight, and state inspection, do not automatically apply to a sober living home. Families can check quality through voluntary standards instead: the National Alliance for Recovery Residences (NARR) defines four levels of recovery residence support, from Level I (peer-run, no paid staff) to Level IV (a clinical setting that is usually a licensed program). Asking which level a home operates at, and whether it is certified by a NARR affiliate, is the fastest way to know what a given house actually offers.

Sober living is housing with structure. It is not treatment. A good home expects residents to be engaged in treatment somewhere else, usually an outpatient or intensive outpatient program, plus mutual-support meetings, work, or school. If a home describes itself as providing therapy, medication management, or detox without a DHCS license, that is a question worth asking directly.

Why the Weeks After Residential Treatment Carry Extra Risk

The National Institute on Drug Abuse describes addiction as a chronic condition and notes that remaining in treatment for an adequate period is important to good outcomes (see NIDA’s Principles of Drug Addiction Treatment). The step down from 24-hour care is where that continuity is easiest to lose. Several things change on the same day:

  • Structure drops away: a residential schedule fills nearly every hour, and discharge can leave whole afternoons empty.
  • Tolerance is lower: after a period without opioids, a return to a previous dose can cause an overdose, which is why naloxone should go home with anyone who has used opioids.
  • Old cues return: the same streets, contacts, and stressors that were present before treatment are there waiting.
  • Accountability thins out: no one is checking in at breakfast, and early warning signs can go unnoticed for days.

A sober living home is one way to keep some of that structure in place while a person rebuilds work, relationships, and outpatient care.

What We See in Placement Work

At Bodhi, our work is matching people with treatment programs and the housing that follows them. A few patterns come up again and again, and none of them appear on a home’s website.

Medication policies vary more than families expect. Some homes do not accept residents who take buprenorphine, methadone, or certain psychiatric medications, even when those medications were prescribed during treatment. Medications for opioid use disorder are an evidence-based standard of care, and a person should not have to choose between their prescription and their housing. We confirm the policy in writing before a referral, every time.

The bed is often the bottleneck, not the money. Well-run homes near the Bay Area and Santa Cruz County can have waiting lists. When discharge is set but housing is not, people end up going “home for a few days” that turn into weeks. The housing search should start in the second or third week of a residential stay, not the last day.

“Zero tolerance” means different things. In some homes a single positive test means immediate eviction with nowhere to go that night. In others, a return to use triggers a meeting, a safety plan, and a referral back to a higher level of care. Families should know which kind of house they are choosing before anything goes wrong.

Seven Questions to Ask Before Move-In

Bring this list to the tour or the phone call. Ask the house manager to answer in writing, by email or text, so there is a record.

  1. What NARR level do you operate at, and are you certified by a NARR affiliate? Ask for the certifying organization and the date the certification was last renewed.
  2. What is your policy on prescribed medications, including buprenorphine, methadone, naltrexone, and psychiatric medications? How are they stored?
  3. What happens after a return to use? Is there a written relapse policy, and where does the resident go if they must leave?
  4. How often is drug and alcohol testing done, and who pays for it?
  5. What are the total move-in costs? Ask for the deposit, the first payment, weekly or monthly rent, and any program fees as separate line items.
  6. Is there an on-site house manager, and what hours are they present?
  7. What outside participation is required? Outpatient treatment, meetings, employment, curfew, and visitor rules should all be spelled out.

If a home cannot or will not answer these questions, that is useful information too. You can also call our team at (877) 328-1968 and we will walk through the answers with you.

Safety Rules That Apply Whatever the Housing

Sober living homes are not medical settings. If someone returns to heavy drinking or to regular benzodiazepine use and then stops suddenly, withdrawal can cause seizures and can be life-threatening. That person needs medically supervised withdrawal management, not a night of rest at the house. The same is true for anyone showing confusion, hallucinations, a high fever, or severe agitation after stopping a substance. Call 911 in an emergency.

Anyone who has used opioids should keep naloxone in their room and make sure housemates know where it is. Families can find treatment and support options through the SAMHSA National Helpline, which is free, confidential, and available 24 hours a day at 1-800-662-4357. If someone is in emotional crisis or thinking about suicide, call or text 988.

How Sober Living Fits the Discharge Plan

Sober living works best as one piece of a written continuing care plan, not a standalone solution. The American Society of Addiction Medicine’s ASAM Criteria describe care as a continuum, with people moving between levels of intensity as their needs change. In practice, a solid plan names all of the following before discharge day:

  • The sober living address and move-in date
  • The outpatient or intensive outpatient program, with a first appointment date already booked
  • The prescriber who will continue any medications, and the date of the first refill
  • A primary support person, and what they should do if they notice warning signs
  • A clear “if things go wrong” step, such as who to call to return to a higher level of care

One thing you can do today: if a loved one is currently in residential treatment, ask their case manager at the next family call, “Which sober living homes are you considering, and what is each one’s medication and relapse policy?” If the answer is that housing has not been discussed yet, ask to put it on the agenda this week.

Getting Help Choosing the Right Next Step

Choosing housing after treatment can feel like one more decision on top of a dozen others. You do not have to sort through it alone. Our treatment consultants help Northern California families compare residential programs, outpatient options, and recovery residences, and we check the details that matter before a referral is made. Call (877) 328-1968 to talk through your situation.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Sober living policies and California regulations can change, so confirm current details directly with the home and the relevant agency. If you or someone you love is in immediate danger, call 911. For a mental health crisis, call or text 988.

/by

Going Home With Naloxone After Residential Treatment: How to Get It in California, Where to Keep It, and the Two-Dose Rule

, , ,
signs of fentanyl overdose

Most discharge plans from residential treatment cover the big items: aftercare appointments, a sober-living or home arrangement, medications, and a relapse prevention plan. One item is easy to treat as an afterthought, and it should not be: leaving with naloxone, and making sure the people at home know how to use it. This post walks through the logistics in California, how to get it, where to keep it, how the two-dose instruction works, and the household check to run on your first night home.

The Short Version

Naloxone is a medication that can temporarily reverse an opioid overdose, and in March 2023 the U.S. Food and Drug Administration approved 4 mg naloxone nasal spray for sale over the counter, without a prescription. The package directions tell the person responding to call 911, give one spray into one nostril, and, if the person does not respond within 2 to 3 minutes, give a second dose in the other nostril using a new device. Because naloxone can wear off before the opioid does, the person still needs emergency medical care even after they wake up. Anyone leaving residential treatment for an opioid use disorder, or for any substance use where the supply could contain fentanyl, should go home with at least two doses, and at least two other people in the household should know exactly where those doses are kept.

Why the Weeks After Discharge Carry Real Risk

Federal health agencies, including the National Institute on Drug Abuse and the Centers for Disease Control and Prevention, describe several factors that raise overdose risk after a period without opioids. Each one applies directly to someone finishing a residential stay:

  • Lost tolerance: After weeks without opioids, the body no longer handles the amount a person used before, so returning to a familiar dose can stop breathing.
  • Unknown supply: Fentanyl is now found in pills, powders, and stimulants sold as something else, so a person who never intended to use an opioid can still be exposed to one.
  • Using alone: A return to use after treatment is often hidden out of shame, which means no one is in the room to respond.
  • Mixing with sedatives: Alcohol and benzodiazepines slow breathing on their own, and combined with opioids the effect compounds.

None of this means a return to use is expected. Many people leave residential care with strong plans and never need naloxone. It means the cost of having it and not needing it is very low, and the cost of needing it and not having it is not.

What We See in Discharge Planning

From my vantage point as a certified addiction counselor and interventionist who sits in on discharge planning, the most common gap is not that the person has no naloxone. It is that the naloxone exists, but only the person in recovery knows where it is. It is in their backpack, their glove box, or a bathroom drawer, and the parent, partner, or roommate who would actually find them has never held the device. In an overdose, the person who needs the naloxone cannot give it to themselves. The plan has to live with the people around them.

The second gap we see is embarrassment on both sides. Families worry that bringing naloxone home signals they expect a relapse. People in recovery worry the same thing. We encourage families to frame it the way they would a fire extinguisher: it is in the kitchen because the house matters, not because anyone plans a fire. Our residential treatment team treats this as a standard part of the discharge conversation rather than a special warning.

How to Get Naloxone in California

There are several routes, and most people can have it in hand the same day:

  • Over the counter: Since the 2023 FDA approval, 4 mg nasal spray is sold on pharmacy shelves and at many retail stores without a prescription.
  • From a pharmacist: California law allows pharmacists to furnish naloxone directly without a prescription from a doctor, which can matter if you want a different formulation or want to bill insurance.
  • Through insurance: Many health plans cover naloxone when a prescription is written. Ask the treatment program’s prescriber whether a prescription can be sent to your pharmacy before discharge so the cost question is settled in advance.
  • Through community programs: County public health departments and community organizations in California often distribute naloxone at no cost. The SAMHSA National Helpline can point you to local resources.

If you are still arranging admission or discharge and want help sorting out the logistics, you can reach our admissions team at (877) 328-1968.

Where to Keep It and What to Check

Naloxone nasal spray should be stored at room temperature, out of direct sunlight, and in its original packaging. Hot cars are a common problem in California summers, so a car should not be the only place a household keeps it. Every package carries an expiration date. Write that date somewhere you will see it, such as a phone calendar reminder a month before it expires.

Pick one fixed, visible spot in the home, such as the kitchen or the main bathroom, and keep it there. A second set can go in the bag of the person in recovery. The rule is that everyone in the house can name the location without thinking.

The Two-Dose Instruction, Step by Step

Follow the directions printed on the package you have, because they are the authoritative version for that product. For the common 4 mg nasal spray, the steps generally look like this:

  1. Try to wake the person. Shout their name and rub firmly on the center of their chest. Signs of an opioid overdose can include slow or stopped breathing, blue or gray lips or fingertips, pinpoint pupils, and being unresponsive.
  2. Call 911. Say the person is not breathing or will not wake up.
  3. Lay the person on their back, insert the nozzle into one nostril, and press the plunger fully.
  4. If they do not respond within 2 to 3 minutes, give a second dose in the other nostril with a new device.
  5. If they are breathing, roll them onto their side. Stay with them until emergency responders arrive, even if they wake up.

Naloxone works only on opioids. It will not reverse an overdose caused by alcohol, benzodiazepines, or stimulants alone. But because fentanyl contamination is so common, and because naloxone is not expected to harm someone who has no opioids in their system, responders are generally advised to give it whenever an opioid overdose is possible. California also has a Good Samaritan law that offers some legal protections to people who call for help during an overdose. The protections have limits, but the guidance from public health agencies is consistent: call.

A Related Safety Note on Alcohol and Benzodiazepines

Some people leave residential treatment while still tapering a benzodiazepine, or with a history of heavy alcohol use. Withdrawal from alcohol and from benzodiazepines can cause seizures and can be life-threatening. Never stop either one abruptly after discharge without guidance, and never try to manage that withdrawal at home on your own. If the medication plan changes or a return to drinking happens, the next step is medical supervision, not a home taper.

The Household Check to Run Your First Night Home

This takes about ten minutes, and it is the single most useful thing a family can do on day one:

  1. Count the doses. Confirm there are at least two, and read the expiration date out loud.
  2. Agree on the spot. Put the naloxone in its fixed location while everyone is watching.
  3. Hand it around. Each adult in the house should hold the device and read the package directions once. Practice the motion without pressing the plunger.
  4. Say the sequence. Out loud: “Shout and rub, call 911, spray, wait 2 to 3 minutes, second spray, side position, stay.”
  5. Set the reminder. Put the expiration date in a phone calendar for every adult in the home.

The point is not to dwell on the worst case. It is to make the response automatic.

Questions to Ask Before Discharge

If you or a family member is in residential treatment now, bring these questions to the next discharge-planning meeting: Will the program provide naloxone or send a prescription to my pharmacy? Can a family member attend a short training before I leave? Does my aftercare plan include a clinician I can call if I return to use? Our treatment consultants can help families think through these questions. Call (877) 328-1968 to talk with someone today.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always follow the directions on your naloxone package and the guidance of your health care provider. If someone is unresponsive or not breathing, call 911 immediately. If you or someone you know is in crisis, call or text 988 to reach the 988 Suicide and Crisis Lifeline.

/by

Benzodiazepine Tapering in Residential Treatment: How the Schedule Is Set and What to Confirm Before Admission

, , ,
Prescription bottle with pills on a counter — residential rehab for chronic pain and opioid use disorder

When someone calls our admissions line about alcohol or opioids, a benzodiazepine prescription often comes up almost as an afterthought: “I also take Xanax for sleep,” or “My doctor has had me on clonazepam for years.” That detail changes the admission plan more than almost anything else on the intake form. Benzodiazepines cannot be stopped the way many people expect, and the schedule for coming off them is set by clinical guidance, not by how long a residential stay happens to last.

This post walks through how a benzodiazepine taper is actually planned in residential treatment, what the published guidance says about pace, and what you should confirm with a program before you arrive.

Why Benzodiazepines Are Handled Differently at Admission

Benzodiazepines, including alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), and diazepam (Valium), act on the brain’s GABA system. With daily use over weeks or months, the brain adapts. Remove the medication suddenly and that adaptation is left unopposed.

Safety first: stopping a benzodiazepine abruptly after regular use can cause withdrawal seizures, which can be life-threatening. The same is true of alcohol. Anyone who has been using benzodiazepines or alcohol daily should not stop on their own, cut down sharply before a bed opens, or “detox at home” without medical supervision. If you are in that situation now, call us at (877) 328-1968 before changing anything.

The mechanism matters because it explains why programs ask so many questions on the first call. In our admissions work, the families who are most surprised are those whose loved one was prescribed the medication legitimately. Dependence is a physical adaptation, and it can develop whether the prescription was followed exactly or not. The National Institute on Drug Abuse describes this distinction between physical dependence and addiction in its overview of prescription medicine misuse.

What the Published Guidance Says About Taper Pace

In 2025, the American Society of Addiction Medicine and a group of partner medical societies released a joint clinical practice guideline on benzodiazepine tapering. It is the reference point most clinicians now use, and it is the document worth asking a program about by name.

A benzodiazepine taper for someone with long-term daily use is usually measured in weeks to months, not days. The joint clinical practice guideline on benzodiazepine tapering, published in 2025 by the American Society of Addiction Medicine and partner medical societies, describes a typical starting pace of dose reductions of about 5 to 10 percent every 2 to 4 weeks, and generally advises against reductions larger than 25 percent in any 2-week period. That means a person entering a 30- to 45-day residential program on a daily benzodiazepine will often still be tapering at discharge, and the discharge plan needs a named prescriber to continue the schedule.

Pace is individualized. The guideline describes adjusting speed based on how the person tolerates each step, and pausing when symptoms are significant. Some people move faster under close supervision; some need much longer. You can read the guideline summary through ASAM’s clinical guidelines page.

The U.S. Food and Drug Administration added a boxed warning to all benzodiazepines in 2020 covering misuse, dependence, and withdrawal reactions, including the risk of abrupt discontinuation. That warning is one reason prescribers have become more cautious about both starting and stopping these medications quickly.

What Drives the Taper Schedule

When our clinical team builds a taper plan, these are the factors that shape it:

  • Duration of use: months or years of daily use generally call for a slower taper than a few weeks of use.
  • Dose and drug: short-acting drugs like alprazolam can produce sharper swings between doses than longer-acting ones, which is why some prescribers convert to a longer-acting benzodiazepine before reducing.
  • Alcohol or other sedatives: combined use of alcohol and benzodiazepines raises withdrawal risk and requires more intensive medical monitoring.
  • Seizure history: any prior withdrawal seizure moves the plan toward a slower, more closely supervised schedule.
  • Co-occurring anxiety or insomnia: the original reason for the prescription does not go away during a taper, so it needs its own treatment plan, often therapy-based.
  • Opioid use or medication for opioid use disorder: the combination of opioids and benzodiazepines increases overdose risk, and coordination between prescribers is essential. The CDC addresses this risk in its overdose prevention resources.

What the First Weeks Actually Look Like

People expect withdrawal to feel like a single hard week. With a properly paced taper, it is usually quieter and longer than that. In the early reductions, clients commonly describe rebound anxiety, lighter or broken sleep, irritability, and a sense of being “on edge” in the evening. Some notice sensitivity to light or sound. Families on visiting days often say their loved one seems more anxious than before treatment, and they worry the program is not working.

That is often what a taper feels like when it is working. The nervous system is readjusting step by step, and each reduction is followed by a period of settling before the next one. This is where residential care earns its place: nursing staff can watch vital signs and symptoms daily, the prescriber can hold a step if needed, and the person is learning non-medication tools for anxiety and sleep in real time, during the exact hours when the old medication used to do that job.

The inconvenient truth from the admissions side is that the hardest conversation is often not about the drug at all. It is telling someone that their benzodiazepine taper will likely continue after they leave our residential program, and that the most important document they take home may be the outpatient prescriber’s appointment, not the discharge summary.

Five Things to Confirm Before Admission

If you or a family member takes a benzodiazepine daily, ask these questions on the admissions call. Write down the answers.

  1. Who manages the taper? Ask for the role of the person who will set and adjust the schedule, such as a physician or psychiatric nurse practitioner, and how often they see clients.
  2. Is the program medically equipped for sedative withdrawal? Ask what level of medical monitoring is available on site and what happens if symptoms escalate. Our residential treatment page explains how care is structured.
  3. Bring every prescription bottle. Bring the actual bottles, with current labels, plus the name and phone number of the prescribing doctor. Today, check the label: write down the drug name, dose, and how many tablets are taken each day. That single list speeds up the medical assessment.
  4. What happens to the taper at discharge? Ask whether the program coordinates a hand-off to an outpatient prescriber and whether that appointment is booked before you leave.
  5. What does insurance cover? Medically monitored withdrawal management may be billed differently than residential care. You can start with a confidential insurance verification.

Do not reduce your dose in the days before admission to “get a head start.” A sudden cut while you wait for a bed is exactly the kind of change that carries seizure risk.

How We Approach This at Bodhi

At Bodhi Addiction Treatment in Northern California, benzodiazepine tapers are planned individually, with medical oversight and a discharge plan that names who continues the schedule. Our clinical approach reflects the practice experience of our founder, Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i, and our team’s work with clients managing both substance use and the anxiety that often came before it.

If you are unsure whether a current prescription affects your admission, the fastest step is to ask. Call (877) 328-1968 and have the prescription label in front of you. If you need help finding treatment anywhere in the country, SAMHSA’s National Helpline is free, confidential, and available 24 hours a day at 1-800-662-4357. If you are in crisis or thinking about harming yourself, call or text 988.

This article is for educational purposes only and is not medical advice. Do not start, stop, or change the dose of any medication without guidance from a qualified healthcare provider. Benzodiazepine and alcohol withdrawal can be dangerous and require medical supervision. If you are experiencing a medical emergency, call 911.

/by

Paying for Residential Treatment Without Insurance: The Good Faith Estimate, the $400 Dispute Rule, and What to Get in Writing

, ,
Clinician consulting a person with cocaine induced psychosis in residential stabilization

Families who call us about paying for residential treatment out of pocket usually have one number in front of them: the weekly or monthly rate a program quoted on the phone. In our placement work, that number is rarely the number on the final bill. The gap is not always bad faith. It is usually the difference between what the program considers “the program” and what the family assumed was included. This guide explains the federal protections that apply when you pay without insurance, the line items that most often fall outside a quote, and exactly what to ask for in writing before admission.

The Good Faith Estimate: The Federal Right Most Self-Pay Families Never Use

Under the federal No Surprises Act, in effect since January 1, 2022, a person who is uninsured or chooses not to use insurance for residential addiction treatment has the right to a written Good Faith Estimate of expected charges before care begins. When the stay is scheduled at least three business days ahead, the provider must deliver the estimate within one business day of scheduling; when it is scheduled ten or more business days ahead, within three business days. If the final bill from a provider or facility comes in at least $400 above its estimate, the patient can start a federal patient-provider dispute within 120 calendar days of the date on that bill. The Centers for Medicare & Medicaid Services explains these rights on its No Surprises Act consumer page.

Two practical points matter here. First, you can ask for the estimate even before you have a date, and you should ask in writing so there is a record of the request. Second, the estimate is only as useful as its line items. A single figure labeled “30-day program” tells you very little about what will be billed separately. If a program tells you the rule does not apply to them, ask them to explain why in an email. A licensed program that is confident in its pricing will not mind putting it on paper.

Why Self-Pay Bills End Up Higher Than the Quote

When we review quotes side by side for families, the same handful of causes accounts for nearly every surprise. None of them require anyone to be dishonest. They come from vague language at the front door.

  • Detox billed as a separate level of care: Many residential programs quote the residential rate only, and medically monitored withdrawal management is priced and sometimes delivered by a different provider.
  • Psychiatry outside the daily rate: A psychiatric evaluation and follow-up medication management visits are often billed by an independent prescriber rather than the facility.
  • Medications and lab work passed through: Prescriptions, drug screens, and blood work may be billed at cost or by an outside pharmacy or laboratory.
  • Off-site medical care: An urgent care visit, dental emergency, or hospital trip during the stay is almost never included in a program rate.
  • Deposits and refund terms nobody read: A nonrefundable deposit or a “no refund after day seven” clause matters a great deal, because the urge to leave early is common in the first week of treatment.

Each of these is a fair business practice on its own. The problem is that families compare a residential-only quote from one program against an all-inclusive quote from another and pick the wrong one as the “cheaper” option.

What “All-Inclusive” Should Mean in Writing

“All-inclusive” is a marketing phrase, not a contract term. Before you sign anything, ask the admissions coordinator to list, item by item, what the quoted rate covers. A complete answer should address room and board, individual therapy sessions per week, group programming, family sessions, case management, medical monitoring during withdrawal, psychiatric care, medications, drug testing, lab work, transportation, and discharge planning. If something is excluded, the quote should say who bills for it and roughly what it costs.

It also helps to know which level of care you are actually buying. The ASAM Criteria, the framework most programs use to match people to care, distinguishes clinically managed residential services from medically monitored and medically managed services. Those differ in staffing and in what they can safely handle, and they are priced differently. Our overview of residential treatment walks through what each setting typically provides.

A Safety Note Before Anyone Tries to Save on Detox

We sometimes hear from families who plan to have their loved one “get through withdrawal at home” so they only pay for the residential portion. For alcohol and benzodiazepines, that plan can be dangerous. Withdrawal from either can cause seizures and, with alcohol, delirium tremens, both of which can be life-threatening. Medical supervision is required for anyone who has been drinking heavily and daily or taking benzodiazepines regularly, and benzodiazepines should never be stopped abruptly without a prescriber directing a taper. The National Institute on Alcohol Abuse and Alcoholism publishes clinical guidance on why alcohol withdrawal needs to be medically assessed. If the quote does not include withdrawal management, the answer is to price it properly, not to skip it.

The Email to Send Before You Pay a Deposit

This is the step we ask every self-pay family to take today, before any money changes hands. Copy the questions below into an email to the program’s admissions or billing contact and keep the reply.

  1. Please send a written Good Faith Estimate for a stay of [number] days, with each expected charge listed separately.
  2. Which of these are billed by your facility, and which are billed by outside providers (psychiatry, pharmacy, laboratory, medical detox)? Please give estimated amounts for each.
  3. What is your state license number, and which level of care is this stay licensed to provide?
  4. How much is the deposit, is any of it refundable, and what is the refund policy if the stay ends early for any reason?
  5. Who confirms the discharge plan, and is aftercare scheduling included in the rate?

If the answers come back incomplete, that tells you something too. In our experience, programs that answer all five clearly are the same programs that communicate well with families during the stay. If you would like help reading a quote, our team can review it with you at no cost. Call (877) 328-1968 or request a treatment consultation.

Check Your Coverage Before Assuming You Are Self-Pay

Many people who start out planning to pay privately have more coverage than they think. Federal parity law generally requires most health plans that cover substance use disorder treatment to do so on terms comparable to medical and surgical care, and California law adds its own medical necessity requirements for plans it regulates. A denial or an out-of-network plan is not always the end of the conversation. Before committing to a full private-pay rate, it is worth a free insurance verification so you know which parts of the stay might be covered and which truly will be out of pocket.

If cost is the barrier that is stopping someone from getting care at all, the SAMHSA National Helpline at 1-800-662-4357 is free, confidential, and available 24 hours a day, and it can point families toward state-funded and sliding-scale options. FindTreatment.gov, also run by SAMHSA, lets you filter licensed programs by payment type.

Why Getting This Right Matters for the Outcome

Money conversations feel separate from clinical ones, but they are not. Research summarized by the National Institute on Drug Abuse emphasizes that staying in treatment for an adequate period matters. A family that runs out of funds on day 18 of a planned 30-day stay, because detox and psychiatry were billed on top, faces a hard choice at exactly the wrong moment. A clear estimate up front lets you plan the full course, including the step-down to outpatient care, instead of discovering the shortfall mid-stay.

Bodhi Addiction Treatment helps individuals and families across Northern California compare residential options, understand what a quote covers, and plan the stay from admission through discharge. If you are weighing private pay, call (877) 328-1968 and we will walk through the numbers with you.

This article is for educational purposes only and is not medical, legal, or financial advice. Billing rules can change and may apply differently depending on the provider and your coverage; confirm details with the program, your plan, or a qualified advisor. If you or someone you love is in crisis, call or text 988 for the 988 Suicide & Crisis Lifeline, or call 911 in an emergency.

/by